Beneficial effects of simvastatin may be due to non-lipid actions

BMJ 1995; 311 doi: http://dx.doi.org/10.1136/bmj.311.7017.1436c (Published 25 November 1995)
Cite this as: BMJ 1995;311:1436.4

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Uffe Ravnskov
  1. Specialist in internal medicine Rabygatan 2, S-223 61 Lund, Sweden

    EDITOR,--On the basis of new trial evidence Michael Oliver and colleagues claim that there is no longer any controversy about cholesterol lowering as secondary prevention of atherosclerosis and coronary heart disease.1 To reach this conclusion they have disregarded many conflicting findings.

    According to Oliver and colleagues, the first principle of the lipid hypothesis is the association between a raised plasma cholesterol concentration and risk of coronary heart disease. This association, however, has been found mainly in people without previous disease. A strong, graded, positive correlation has …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL